Maier, C., Fuchs, J., Irrgang, P., Wißing, M. H., Beyerlein, J., Tenbusch, M., & Lapuente, D. (2022). Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Maier, Clara, Jana Fuchs, Pascal Irrgang, Michael Hermann Wißing, Jasmin Beyerlein, Matthias Tenbusch, und Dennis Lapuente. Mucosal Immunization with an Adenoviral Vector Vaccine Confers Superior Protection Against RSV Compared to Natural Immunity. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.
MLA-Zitierstil (9. Ausg.)Maier, Clara, et al. Mucosal Immunization with an Adenoviral Vector Vaccine Confers Superior Protection Against RSV Compared to Natural Immunity. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.